- SG$27.87m
- SG$25.02m
- SG$12.58m
- 100
- 64
- 81
- 96
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.7 | ||
| Price to Tang. Book | 3.66 | ||
| Price to Free Cashflow | 8.78 | ||
| Price to Sales | 2.17 | ||
| EV to EBITDA | 11.24 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.83% | ||
| Return on Equity | 9.21% | ||
| Operating Margin | 12.09% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 16.74 | 10.79 | 11.99 | 12.97 | 12.58 | n/a | n/a | 6.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +66.23 | -20.03 | +7.13 | -45.83 | -8.63 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medinex Limited is an investment holding company. Its principal activities include providing business support services, medical support services, and pharmaceutical services. The Company's segments comprise medical support services, business support services, pharmaceutical services, and medical services. The medical support services segment offers professional services to clients in the primary and secondary healthcare sectors, including general practitioners and specialists. The business support services segment provides professional services to customer bases outside the healthcare industry. The pharmaceutical services segment distributes medical and pharmaceutical products to clinics. The medical services segment offers x-rays, pre-employment check-ups, and health screening in clinics located in Singapore. The Company's subsidiaries include Medinex Corporate Services Pte. Ltd., Medinex Healthcare Services Pte. Ltd., and Nex Healthcare Pte. Ltd.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- January 12th, 2009
- Public Since
- December 7th, 2018
- No. of Employees
- 80
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Singapore Exchange Securities Trading Ltd- Shares in Issue
- 132,691,176
- Address
- 111 North Bridge Road, 179098
- Web
- https://medinex.com.sg/
- Phone
- +65 66046330
- Auditors
- Forvis Mazars
Upcoming Events for OTX
Similar to OTX
Abundance International
Singapore Exchange Securities Trading Ltd
Acesian Partners
Singapore Exchange Securities Trading Ltd
Advancer Global
Singapore Exchange Securities Trading Ltd
A-Smart Holdings
Singapore Exchange Securities Trading Ltd
Bacui Technologies International
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 03:57 UTC, shares in Medinex are trading at SG$0.21. This share price information is delayed by 15 minutes.
Shares in Medinex last closed at SG$0.21 and the price had moved by +5% over the past 365 days. In terms of relative price strength the Medinex share price has outperformed the FTSE Developed Asia Pacific Index by +6.2% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Medinex dividend yield is 8% based on the trailing twelve month period.
Last year, Medinex paid a total dividend of SG$0.02, and it currently has a trailing dividend yield of 8%. We do not have any data on when Medinex is to next pay dividends.
We do not have data on when Medinex is to next pay dividends. The historic dividend yield on Medinex shares is currently 8%.
To buy shares in Medinex you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$0.21, shares in Medinex had a market capitalisation of SG$27.87m.
Here are the trading details for Medinex:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: OTX
Based on an overall assessment of its quality, value and momentum Medinex is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medinex. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +11.26%.
As of the last closing price of SG$0.21, shares in Medinex were trading +2.48% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medinex PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Medinex's directors